These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32902291)

  • 21. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
    Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo application of RNA interference: from functional genomics to therapeutics.
    Lu PY; Xie F; Woodle MC
    Adv Genet; 2005; 54():117-42. PubMed ID: 16096010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation.
    Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme.
    Chou ST; Patil R; Galstyan A; Gangalum PR; Cavenee WK; Furnari FB; Ljubimov VA; Chesnokova A; Kramerov AA; Ding H; Falahatian V; Mashouf L; Fox I; Black KL; Holler E; Ljubimov AV; Ljubimova JY
    J Control Release; 2016 Dec; 244(Pt A):14-23. PubMed ID: 27825958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme.
    Yan W; Zhang W; Sun L; Liu Y; You G; Wang Y; Kang C; You Y; Jiang T
    Brain Res; 2011 Sep; 1411():108-15. PubMed ID: 21831363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-coding RNAs: Therapeutic Strategies and Delivery Systems.
    Ling H
    Adv Exp Med Biol; 2016; 937():229-37. PubMed ID: 27573903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies.
    Karlsson J; Luly KM; Tzeng SY; Green JJ
    Adv Drug Deliv Rev; 2021 Dec; 179():113999. PubMed ID: 34715258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Achieving successful delivery of oligonucleotides--From physico-chemical characterization to in vivo evaluation.
    Scomparin A; Polyak D; Krivitsky A; Satchi-Fainaro R
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1294-309. PubMed ID: 25916823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA therapeutics for heart disease.
    De Majo F; De Windt LJ
    Biochem Pharmacol; 2018 Sep; 155():468-478. PubMed ID: 30059676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA HOXA-AS3 promotes the malignancy of glioblastoma through regulating miR-455-5p/USP3 axis.
    Chen W; Li Q; Zhang G; Wang H; Zhu Z; Chen L
    J Cell Mol Med; 2020 Oct; 24(20):11755-11767. PubMed ID: 32918360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y
    Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ROS-Responsive Polymeric siRNA Nanomedicine Stabilized by Triple Interactions for the Robust Glioblastoma Combinational RNAi Therapy.
    Zheng M; Liu Y; Wang Y; Zhang D; Zou Y; Ruan W; Yin J; Tao W; Park JB; Shi B
    Adv Mater; 2019 Sep; 31(37):e1903277. PubMed ID: 31348581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noncoding RNA for Cancer Gene Therapy.
    Zhong X; Zhang D; Xiong M; Zhang L
    Recent Results Cancer Res; 2016; 209():51-60. PubMed ID: 28101687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
    Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
    Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Formulation for the Delivery of Oligonucleotides Using "Clickable" siRNA-Polyisoprenoid-Conjugated Nanoparticles: Application to Cancers Harboring Fusion Oncogenes.
    Massaad-Massade L; Boutary S; Caillaud M; Gracia C; Parola B; Gnaouiya SB; Stella B; Arpicco S; Buchy E; Desmaële D; Couvreur P; Urbinati G
    Bioconjug Chem; 2018 Jun; 29(6):1961-1972. PubMed ID: 29727181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis.
    Niemietz C; Chandhok G; Schmidt H
    Molecules; 2015 Sep; 20(10):17944-75. PubMed ID: 26437390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcellular fate and off-target effects of siRNA, shRNA, and miRNA.
    Singh S; Narang AS; Mahato RI
    Pharm Res; 2011 Dec; 28(12):2996-3015. PubMed ID: 22033880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Cancer with Peptide RNAi Nanoplexes.
    Mixson AJ; Leng Q; Chou ST; Woodle MC
    Methods Mol Biol; 2019; 1974():161-180. PubMed ID: 31099002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo rendezvous of small nucleic acid drugs with charge-matched block catiomers to target cancers.
    Watanabe S; Hayashi K; Toh K; Kim HJ; Liu X; Chaya H; Fukushima S; Katsushima K; Kondo Y; Uchida S; Ogura S; Nomoto T; Takemoto H; Cabral H; Kinoh H; Tanaka HY; Kano MR; Matsumoto Y; Fukuhara H; Uchida S; Nangaku M; Osada K; Nishiyama N; Miyata K; Kataoka K
    Nat Commun; 2019 Apr; 10(1):1894. PubMed ID: 31019193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.